Top

Category: Research and Development


Clinical Trials, Research and Development

New Technique Developed to Study Cell Types in Parkinson’s Disease

November 17, 2020

Via: Genetic Engineering and Biotechnology News

Parkinson’s disease (PD) is a progressive disorder that affects nerve cells in the brain responsible for body movement. When dopamine-producing neurons die, symptoms such as tremor, slowness, stiffness, and balance problems occur. Researchers at Carnegie Mellon University (CMU) have developed […]


Clinical Trials, Research and Development

Novel Cell Analysis Tool Bridges In Situ Microscopy and Single Cell Omics

November 12, 2020

Via: Genetic Engineering and Biotechnology News

Scientists have developed a new method that allows them to select individual cells from a population that is growing on the surface of a laboratory dish, and then study their contents using DNA and protein sequencing technologies to analyze the […]


Clinical Trials, Research and Development

Nerve Cell Growth Powered by Printable Ink May Aid Nerve Injury

November 11, 2020

Via: Genetic Engineering and Biotechnology News

Nerve tissue engineering is an application of tissue engineering in peripheral nerve regeneration, and tissue-engineered nerve grafts, like other tissue-engineered constructs, are typically composed of a nerve scaffold combined with cellular and/or molecular components. A team of researchers from RMIT […]


Clinical Trials, Research and Development

Antibody-Drug Combination Regresses Pancreatic Tumor in Mice

November 9, 2020

Via: Genetic Engineering and Biotechnology News

According to the National Cancer Institute, about 10% of patients with pancreatic cancer (PC) remain alive five years after diagnosis. Tumor size has a strong impact on survival rates. The larger the tumor, the less likely it is to be […]


Clinical Trials, FDA, Regulations, Research and Development

FDA authorizes first test that screens for Covid-neutralizing antibodies

November 6, 2020

Via: CNBC

The Food and Drug Administration announced on Friday that it has authorized the first serology test that screens for neutralizing antibodies caused by a previous coronavirus infection. Neutralizing antibodies prevent viruses from infecting cells, though questions remain about how long […]


Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Scientists Map Sensitivity of Thousands of Genes to Chemical Exposure

November 2, 2020

Via: Genetic Engineering and Biotechnology News

Scientists at the University of Massachusetts, Amherst, have used what they claim is an unprecedented objective approach to identify which genes and molecular pathways— including mechanisms involving aging, lipid metabolism, and autoimmune disease—are most sensitive to chemical exposure. Headed by […]


Manufacturing, Research and Development

AB2 Bio and WuXi Biologics Collaborate on Orphan Drug Manufacture

October 30, 2020

Via: Genetic Engineering and Biotechnology News

AB2 Bio, a Swiss clinical-stage biotech company developing therapies for the treatment of severe systemic autoinflammatory diseases, and WuXi Biologics agreed to collaborate to set up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s recombinant IL-18 binding protein. AB2 […]


Clinical Trials, Research and Development

Clinical Research Program and COVID-19 Collaboration Launched in Nigeria

October 28, 2020

Via: Genetic Engineering and Biotechnology News

Today, 54gene announced the launch of its Clinical Program Services (CPS) division. The CPS division is focused on partnering with global pharmaceutical and biotechnology companies, and multilateral health organizations to discover, develop, and commercialize new therapeutic and diagnostic products. 54gene, […]


Clinical Trials, Research and Development

Novavax provides Phase 3 COVID-19 vaccine clinical development update

October 27, 2020

Via: World Pharma News

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19 vaccine candidate. NVX‑CoV2373 is a stable, prefusion protein made using Novavax’ nanoparticle […]


Industry, Manufacturing, Research and Development, Vaccines

Medigene and Cytovant Sign Vaccine Manufacturing Deal

October 27, 2020

Via: Genetic Engineering and Biotechnology News

Medigene, clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for cancer, entered into a service agreement with Cytovant Sciences to support process development activities for the manufacturing of dendritic cell (DC) vaccines. The deal builds on […]


Clinical Trials, FDA, Regulations, Research and Development

Alnylam makes case for lumasiran in infants ahead of FDA ruling  

October 23, 2020

Via: FierceBiotech

Alnylam has shared data from a phase 3 trial of its near-approval kidney disease drug lumasiran in children as young as three months. The RNAi therapy drove a 72% reduction in urinary oxalate from baseline, boosting Alnylam’s hopes of using […]


Clinical Trials, Research and Development

SARS-CoV-2 Infection Modeled in 3-D Stem Cell Culture Model

October 23, 2020

Via: Genetic Engineering and Biotechnology News

Understanding how SARS-CoV-2 infection damages the lungs is paramount to developing better treatments. Now, “mini-lungs” grown from tissue donated to Cambridge hospitals has provided a team of scientists with important insights into how COVID-19 damages the lungs. In new work, […]